BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9155658)

  • 21. An assessment of the statistical methods used to analyse toxicology studies.
    Jarvis P; Saul J; Aylott M; Bate S; Geys H; Sherington J
    Pharm Stat; 2011; 10(6):477-84. PubMed ID: 22140058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Need for dietary control by caloric restriction in rodent toxicology and carcinogenicity studies.
    Keenan KP; Laroque P; Dixit R
    J Toxicol Environ Health B Crit Rev; 1998; 1(2):135-48. PubMed ID: 9650534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A strategy for the application of transgenic rodent mutagenesis assays.
    Gorelick NJ; Mirsalis JC
    Environ Mol Mutagen; 1996; 28(4):434-42. PubMed ID: 8991075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1.2 Aspects of test assessment.
    Hoffmann S
    Hum Exp Toxicol; 2009 Feb; 28(2-3):95-6. PubMed ID: 19713368
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of human cell line reporter gene-based assays in chemical toxicity testing.
    Scrivens M; Bhogal N
    Toxicol In Vitro; 2007 Oct; 21(7):1233-40. PubMed ID: 17604594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of short-and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. Consensus report.
    IARC Sci Publ; 1999; (146):1-18. PubMed ID: 10353381
    [No Abstract]   [Full Text] [Related]  

  • 29. Transgenic animals in toxicology.
    Ladiges WC; Ware CB
    Curr Protoc Toxicol; 2001; Chapter 1():Unit1.3. PubMed ID: 23045021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment.
    Blakey D; Galloway SM; Kirkland DJ; MacGregor JT
    Mutat Res; 2008 Nov; 657(1):84-90. PubMed ID: 18926925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of mutations in transgenic animal models: BigBlue and Muta Mouse.
    Schmezer P; Eckert C
    IARC Sci Publ; 1999; (146):367-94. PubMed ID: 10353395
    [No Abstract]   [Full Text] [Related]  

  • 32. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Putting chemicals on a path to better risk assessment.
    Stokstad E
    Science; 2009 Aug; 325(5941):694-5. PubMed ID: 19661414
    [No Abstract]   [Full Text] [Related]  

  • 34. Carcinogenesis. Testing times for the tests.
    Hay A
    Nature; 1991 Apr; 350(6319):555-6. PubMed ID: 2017254
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on national toxicology program (NTP) assays with genetically altered or "transgenic" mice.
    Bucher JR
    Environ Health Perspect; 1998 Oct; 106(10):619-21. PubMed ID: 9755135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity testing gets a makeover.
    Abbott A
    Nature; 2009 Sep; 461(7261):158. PubMed ID: 19741676
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of fish cells in ecotoxicology. The report and recommendations of ECVAM Workshop 47.
    Castaño A; Bols N; Braunbeck T; Dierickx P; Halder M; Isomaa B; Kawahara K; Lee LE; Mothersill C; Pärt P; Repetto G; Sintes JR; Rufli H; Smith R; Wood C; Segner H;
    Altern Lab Anim; 2003; 31(3):317-51. PubMed ID: 15612875
    [No Abstract]   [Full Text] [Related]  

  • 38. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI.
    MacDonald J; French JE; Gerson RJ; Goodman J; Inoue T; Jacobs A; Kasper P; Keller D; Lavin A; Long G; McCullough B; Sistare FD; Storer R; van der Laan JW
    Toxicol Sci; 2004 Feb; 77(2):188-94. PubMed ID: 14657512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 40. Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutat Res; 2010; 705(1):20-39. PubMed ID: 20206292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.